NASD · Healthcare · Medical Devices · Canada
Profound Medical Corp is a micro cap company (market value under $300 million) in the Medical Devices industry.
Profound Medical is a medical device company that creates MRI-guided ablation systems for removing diseased tissue without surgical incisions. The TULSA-PRO system treats prostate cancer and benign conditions using focused ultrasound with real-time temperature monitoring. The Sonalleve system addresses uterine fibroids, bone metastases, and other conditions, with approvals across the United States, Europe, and Asia.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Profound Medical Corp stock.
Undervalued: intrinsic value $22.67 per share, market price $6.57, margin of safety 71.0% (as of 2026-10-30).
Its through-the-cycle earnings (377.8% median margin), capitalised at 9.3% with no growth, values the shares at $22.67; the price of $6.57 is 71% below that value.
Leak Score: 53/100 on 9 of 12 signals (Weak Signal).
All 142 Medical Devices stocks
PROF is undervalued (as of the 2026-10-30 close). Its through-the-cycle earnings (377.8% median margin), capitalised at 9.3% with no growth, values the shares at $22.67; the price of $6.57 is 71% below that value.
$22.67 per share (as of the 2026-10-30 close), against a market price of $6.57. That is a margin of safety of 71.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
53 out of 100, which we rate "Weak Signal", on 9 of 12 value investing signals.